SYK

In the past six months, Stryker Corp.'s stock price has experienced significant pressure, decreasing by 27.03% over the last 12 months and 16.21% in the past month as of September 19, 2026. A major event impacting the stock was a cyberattack on March 11, 2026, which disrupted manufacturing, shipments, and revenue recognition for approximately three weeks, leading to a roughly 10% plunge in the stock price. This cyberattack also contributed to a Q1 2026 earnings miss and ongoing manufacturing issues in the peripheral vascular business, which continued to drag down growth in Q2 and Q3 2026, and are expected to persist into Q4. Additionally, softer-than-expected joint replacement demand, particularly hip procedures in Europe, and normal summer seasonality in the U.S. for patient and surgeon vacations in July and August, have also contributed to the stock's underperformance. Macro pressures, such as potential tariffs and softening hospital capital spending, have also affected the broader medtech sector, including Stryker.